Edson Munekata and Freddy Lee took over ownership of one of downtown Wilmington’s riverfront restaurants in 2022. Since then, they’ve been operating The George on the Riverwalk much as it had been.

29 years of love and counting: one Wilmington couple reflects on the moment they fell in love WILMINGTON, N.C. (WECT) - Do you remember the moment you fell in love with your significant other? Gena ...

Camellias, with their beautiful blooms in various colors, are a common sight in Wilmington during winter. The first camellias ...

Welcome to Corner Bistro, Wilmington’s hidden gem that’s serving up soup so good, it might just bring a tear to your eye – ...

That ended when it hived off the latter business as the separately managed and traded Kenvue in mid-2023. These days, the slimmed-down Johnson & Johnson is doing well in the two major areas of the ...

Kenvue Inc. (KVUE), a global consumer health company, is dedicated to delivering trusted personal care, health, and wellness products. Headquartered in Skillman, New Jersey, Kenvue offers a ...

Kenvue Inc . (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson in 2023, finds itself at a critical juncture as it navigates its first full year as an independent entity. The ...

Barclays analyst Lauren Lieberman maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target of $21.00. The company’s shares closed yesterday at $21.72.

Kenvue Inc . (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson in 2023, finds itself at a critical juncture as it navigates its first full year as an independent entity. The ...

Shares of Kenvue Inc. KVUE rallied 1.92% to $21.72 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.53% to 6,071.17 ...

Kenvue (KVUE) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives ...

These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology ...